(Q38714328)

5 September 2017

Pluripotent stem cells in disease modelling and drug discovery (English)

1 reference

5 September 2017

1 reference

1 reference

3

Nissim Benvenisty

1 reference

5 September 2017

Yishai Avior

1

1 reference

5 September 2017

Ido Sagi

series ordinal

2

1 reference

5 September 2017

language of work or name

1 reference

28 January 2016

1 reference

Nature Reviews Molecular Cell Biology

5 September 2017

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

5 September 2017

17

1 reference

5 September 2017

3

1 reference

5 September 2017

170-182

1 reference

https://scigraph.springernature.com/pub.10.1038/nrm.2015.27

5 September 2017

0 references

cites work

Initial sequencing and comparative analysis of the mouse genome

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Homologous recombination in human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Human embryonic stem cells as models for aneuploid chromosomal syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Disease-specific induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Human embryonic stem cells derived by somatic cell nuclear transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

A guide to genome engineering with programmable nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Investigating human disease using stem cell models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induced pluripotent stem cells: the new patient?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Generation of induced pluripotent stem cells from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

International coordination of large-scale human induced pluripotent stem cell initiatives: Wellcome Trust and ISSCR workshops white paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modelling schizophrenia using human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

A TALEN genome-editing system for generating human stem cell-based disease models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Therapeutic genome editing: prospects and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Elucidating molecular phenotypes caused by the SORL1 Alzheimer's disease genetic risk factor using human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Cardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Large-scale screening using familial dysautonomia induced pluripotent stem cells identifies compounds that rescue IKBKAP expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Epidemiology and etiology of Parkinson's disease: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modeling human cortical development in vitro using induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Human iPSC-based modeling of late-onset disease via progerin-induced aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Selective demethylation and altered gene expression are associated with ICF syndrome in human-induced pluripotent stem cells and mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induced pluripotent stem cells as a model for telomeric abnormalities in ICF type I syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

The role of genomic imprinting in biology and disease: an expanding view

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Genomic imprinting: the emergence of an epigenetic paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Characterization of human embryonic stem cell lines by the International Stem Cell Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Epigenetic status of human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Status of genomic imprinting in human embryonic stem cells as revealed by a large cohort of independently derived and maintained lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Imprinted expression of UBE3A in non-neuronal cells from a Prader-Willi syndrome patient with an atypical deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Gonadal teratomas: a review and speculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Patient-specific stem cell lines derived from human parthenogenetic blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Derivation of human embryonic stem cell lines from parthenogenetic blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Cell lines derived from human parthenogenetic embryos can display aberrant centriole distribution and altered expression levels of mitotic spindle check-point transcripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Involvement of parental imprinting in the antisense regulation of onco-miR-372-373.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Self-organizing optic-cup morphogenesis in three-dimensional culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Self-formation of functional adenohypophysis in three-dimensional culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Cerebral organoids model human brain development and microcephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

A functional CFTR assay using primary cystic fibrosis intestinal organoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modeling mouse and human development using organoid cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Organogenesis in a dish: modeling development and disease using organoid technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Quality control: Genome maintenance in pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Comparing ESC and iPSC-Based Models for Human Genetic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Antisense oligonucleotides in therapy for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

From Dish to Bedside: Lessons Learned While Translating Findings from a Stem Cell Model of Disease to a Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Genome-wide RNA-Seq of Human Motor Neurons Implicates Selective ER Stress Activation in Spinal Muscular Atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Epigenetic therapy for Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modeling non-syndromic autism and the impact of TRPC6 disruption in human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induced pluripotent stem cell models from X-linked adrenoleukodystrophy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Drug screening for ALS using patient-specific induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Effect of potent γ-secretase modulator in human neurons derived from multiple presenilin 1-induced pluripotent stem cell mutant carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modeling familial Alzheimer's disease with induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

SMRT compounds abrogate cellular phenotypes of ataxia telangiectasia in neural derivatives of patient-specific hiPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

High-Throughput Screening Using iPSC-Derived Neuronal Progenitors to Identify Compounds Counteracting Epigenetic Gene Silencing in Fragile X Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Unveiling a common mechanism of apoptosis in β-cells and neurons in Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Pathological roles of the VEGF/SphK pathway in Niemann-Pick type C neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Extrapolation from mouse to man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

A decade of transcription factor-mediated reprogramming to pluripotency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Fetal loss in Down syndrome pregnancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Global analysis of parental imprinting in human parthenogenetic induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRM.2015.27

Fetal loss in Down syndrome pregnancies

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26818440

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRM.2015.27

1 reference

Dimensions Publication ID

5 September 2017

0 references

1 reference